Recent Material Events - Marvel Technology Grp Ltd (MRVL)

Filing Date	Description
2008-06-02	Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-05-30	Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-05-08	The information in Item 2.02 of this Current Report is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to ...
2008-05-02	On April 29, 2008, David Mills notified the registrant of his intention to resign from the board of directors, including the governance committee thereof, of the registrant, and on April 30, 2008, Mr. Mills resigned from such positions, effective imm ...
2008-04-04	On March 31, 2008, Dr. Paul Gray notified the registrant of his intention to retire from the board of directors of the registrant (the “Board”). His retirement will be effective April 11, 2008. Dr. Gray is currently Chairman of the Executi ...
2008-03-28	COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN* Among Marvell Technology Group Ltd., The S&P 500 Index And The Philadelphia Semiconductor Index ...
2008-02-06	No new compensation arrangement was entered into in connection with the appointment to the Board of Mr. Mills. Mr. Mills will receive the Company’s standard compensation arrangements applicable to a director who is not an employee of the Company ...
2008-01-23	Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...
2008-01-16	(e) On January 11, 2008, at the request of Dr. Sehat Sutardja, the Chief Executive Officer of Marvell Technology Group, Ltd. (the “Company”), and Dr. Pantas Sutardja, the Company’s Chief Technology Officer, Chief Research and Develop ...
2008-01-02	Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ...